Journal Article DKFZ-2021-00465

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Low positive predictive value of computed tomography screening for lung cancer irrespective of commonly employed definitions of target population.

 ;

2021
Wiley-Liss Bognor Regis

International journal of cancer 149(1), 58-65 () [10.1002/ijc.33522]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: Screening for lung cancer (LC) by low-dose computed tomography (LDCT) has been demonstrated to reduce LC mortality in randomized clinical trials (RCTs), and its implementation is in preparation in many countries. However, definition of the target population, which was based on various combinations of age ranges and definitions of heavy smoking in the RCTs, is subject to ongoing debate. Using epidemiological data from Germany, we aimed to estimate prevalence of preclinical LC and positive predictive value (PPV) of LDCT in potential target populations defined by age and smoking history. Populations aged 50-69, 55-69, 50-74 and 55-79 years were considered in this analysis. Sex-specific prevalence of preclinical LC was estimated using LC incidence data within those age ranges and annual transition rates from preclinical to clinical LC obtained by meta-analysis. Prevalence of preclinical LC among heavy smokers (defined by various pack-year thresholds) within those age ranges was estimated by combining LC prevalence in the general population with proportions of heavy smokers and relative risks for LC among them derived from epidemiological studies. PPVs were calculated by combining these prevalences with sensitivity and specificity estimates of LDCT. Estimated prevalence of LC was 0.3-0.5% (men) and 0.2-0.3% (women) in the general population and 0.8-1.7% in target populations of heavy smokers. Estimates of PPV of LDCT were <20% for all definitions of target populations of heavy smokers. Refined preselection of target populations would be highly desirable to increase PPV and efficiency of LDCT screening and to reduce numbers of false positive LDCT findings.

Keyword(s): lung cancer ; pack-years ; preclinical cancer ; predictive value ; screening

Classification:

Note: #EA:C070#LA:C070# / 149(1):58-65

Contributing Institute(s):
  1. C070 Klinische Epidemiologie und Alternf. (C070)
  2. Präventive Onkologie (C120)
  3. DKTK HD zentral (HD01)
Research Program(s):
  1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2021
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Wiley ; Essential Science Indicators ; IF < 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2021-03-01, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)